Patrizia Cavazzoni, new CDER director

Pa­trizia Cavaz­zoni named per­ma­nent di­rec­tor of CDER, adding to ques­tions around where Wood­cock will end up

Pa­trizia Cavaz­zoni on Mon­day be­came the per­ma­nent di­rec­tor of the FDA’s Cen­ter for Drug Eval­u­a­tion and Re­search, which puts to rest the idea that Janet Wood­cock, Cavaz­zoni’s pre­de­ces­sor, might re­turn to lead CDER if she isn’t made per­ma­nent com­mis­sion­er.

Wood­cock, who’s cur­rent­ly serv­ing as act­ing com­mis­sion­er and prin­ci­pal med­ical ad­vi­sor to the com­mis­sion­er, a po­si­tion she was de­tailed to last year, may not make the move to per­ma­nent com­mis­sion­er be­cause of lin­ger­ing ques­tions from Sen­ate De­moc­rats. She pre­vi­ous­ly served as di­rec­tor of CDER since 1994. Cavaz­zoni took over as act­ing di­rec­tor of CDER when Wood­cock moved over to Op­er­a­tion Warp Speed to run the ther­a­peu­tics side of the Trump-era pro­gram.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.